Published in
Springer Nature [academic journals on nature.com], Leukemia, 9(36), p. 2189-2195, 2022
DOI: 10.1038/s41375-022-01657-3
Links
Tools
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome
Journal article published in 2022 by
J. J. W. M. Janssen 
,
B. Löwenberg,
M. Manz ,
B. J. Biemond,
P. E. Westerweel ,
S. K. Klein ,
M. Fehr,
H. A. M. Sinnige,
A. Efthymiou,
M. C. J. C. Legdeur,
T. Pabst ,
M. Gregor,
M. W. M. van der Poel,
D. Deeren,
L. W. Tick
and other authors.
,
B. Löwenberg,
M. Manz ,
B. J. Biemond,
P. E. Westerweel ,
S. K. Klein ,
M. Fehr,
H. A. M. Sinnige,
A. Efthymiou,
M. C. J. C. Legdeur,
T. Pabst ,
M. Gregor,
M. W. M. van der Poel,
D. Deeren,
L. W. Tick
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 